China Gene Therapy obtained US FDA DesignationAugust 17, 2021
Risk of Cataract Surgery in RPSeptember 22, 2021
Inflammation, oxidative stress and poor ocular circulation are the top three factors that accelerate progressive vision loss in RP. Inflammation and optic cells death are tightly interconnected. Studies propose that inflammation is a consequence of the photoreceptor degeneration triggered by genetic defects. During photoreceptor cell death, inflammatory cells are activated by releasing inflammatory substances that contribute to rod and cone cell death. This eventually accelerates vision loss.
While there are still no effective treatments for most degenerative retinal disorders, except for RPE65 gene therapy. The researchers demonstrate that StemActiv (www.restorevisionherbs.com) regulates inflammation and slows down the progression of RP, mainly through preventing rods and cones death and maintaining the retinal integrity for a longer time.
StemActiv for Better Vision:
Arguably the most effective supplement for retinal neuroprotection and controlling neuro-inflammation – now our TOP supplement recommendation for ALL degenerative retinal disorders including RP, usher-syndrome, Stargardts disease, optic nerve atrophy, macular degeneration.